Startups Converting Plastic into Natural Gas, Improving Electric Motors for Boats, Building Gas-Powered Fuel Cells and a Personalizing Arthritis Treatment Win CHF 10,000
26.07.2019
Spin-off projects from the universities of St Gallen and Geneva, and EPF Lausanne each win Venture Kick’s support and training. The founders of Circular Solutions, ShemaTic, INERGIO and Alibion aim to recycle plastic, provide powerful, tailor-made electric motors for boats, deliver lightweight, fast and high autonomy power units, and improve patient treatment.
 |
 |
 Circular Solutions Co-founder Felix Bobbink on the left
|
|
 ShemaTics' founder and CEO Cedric Flüeli
|
|
 INERGIO's founder Mahmoud Hadad
|
|
 Alibion's COO Anil Kumar, CEO Daniel Rojas, CSO Liliane Goetsch
|
|
Circular Solutions: converting mixed plastics into natural gas
EPFL-based Felix Bobbink’s team are developing a technology that can help reduce plastic pollution. Their process relies on a patented catalyst that converts mixed plastics selectively into natural gas.
ShemaTics: the most-powerful tailor-made electric motors
Europe lacks trustworthy engineering partners able to design tailor-made, high-performance, light and reliable electric motors. Founder and CEO Cédric Flüeli, a graduate at HES-SO Geneva, and co-founder Anthony Girardin have invented a simple and efficient way to build electric motors of any size and quantity, that are three times more powerful than rival designs. ShemaTic are focusing their fast-charging motors on the electric boat market, where sales of recreational boats under 8 meters are expected to be CHF 22 billion next year.
The startup’s first working prototype was built for a jetsurf project on Lake Geneva in June.
INERGIO: Lightweight fuel cells operating on standard butane/propane
INERGIO, an EPFL spin-off, is developing faster, portable energy units that offer ten times the power at half the weight of current technology. Founder Mahmoud Hadad’s fuel cell innovation, which uses standard butane or propane that’s safe and available worldwide, offers high autonomy. INERGIO’s fuel cell geometry allows unlimited scaling, making the technology suitable for applications ranging from charging consumer electronics to auxiliary power for drones to automobile fuel cells.
venturekick.ch/INERGIO
Alibion: the first personalized therapy for rheumatoid arthritis
Currently, most rheumatoid arthritis patients don’t receive effective treatment, because doctors don’t have a scientific rationale for choosing one specific treatment over another. University of St. Gallen alums Liliane Goetsch, Anil Kumar, Daniel Rojas and Andreas Schulze are developing a small molecule to tackle this.
Alibion’s candidate drug, which about to start preclinical testing, uses a personalized medicine approach. The treatment will target the inflammation and painful bone erosion for patients whose gene suggest are at high-risk of developing arthritis,
EPFL-based Felix Bobbink’s team are developing a technology that can help reduce plastic pollution. Their process relies on a patented catalyst that converts mixed plastics selectively into natural gas.
ShemaTics: the most-powerful tailor-made electric motors
Europe lacks trustworthy engineering partners able to design tailor-made, high-performance, light and reliable electric motors. Founder and CEO Cédric Flüeli, a graduate at HES-SO Geneva, and co-founder Anthony Girardin have invented a simple and efficient way to build electric motors of any size and quantity, that are three times more powerful than rival designs. ShemaTic are focusing their fast-charging motors on the electric boat market, where sales of recreational boats under 8 meters are expected to be CHF 22 billion next year.
The startup’s first working prototype was built for a jetsurf project on Lake Geneva in June.
INERGIO: Lightweight fuel cells operating on standard butane/propane
INERGIO, an EPFL spin-off, is developing faster, portable energy units that offer ten times the power at half the weight of current technology. Founder Mahmoud Hadad’s fuel cell innovation, which uses standard butane or propane that’s safe and available worldwide, offers high autonomy. INERGIO’s fuel cell geometry allows unlimited scaling, making the technology suitable for applications ranging from charging consumer electronics to auxiliary power for drones to automobile fuel cells.
venturekick.ch/INERGIO
Alibion: the first personalized therapy for rheumatoid arthritis
Currently, most rheumatoid arthritis patients don’t receive effective treatment, because doctors don’t have a scientific rationale for choosing one specific treatment over another. University of St. Gallen alums Liliane Goetsch, Anil Kumar, Daniel Rojas and Andreas Schulze are developing a small molecule to tackle this.
Alibion’s candidate drug, which about to start preclinical testing, uses a personalized medicine approach. The treatment will target the inflammation and painful bone erosion for patients whose gene suggest are at high-risk of developing arthritis,